Thank you.
I believe that few understand the potential with respect to the Benitec agreement and that many are ready to discount it as they have so many other significant advancements this company has made. Just as they have viciously attacked the company's A/S increases as nothing more than Dr. Koos lining his pockets. When in reality, this company that has been diligently working to secure products to be sold has utilized these increases as means to pay the bills, fund research, secure allegiances with prominent and respected teams and maintaining autonomy.
They do not move at the behest of any governmental agencies because they are functioning off a grant or another form of public assistance. They are doing all that they have promised they would do and doing so privately.
I agree that the pps will not move significantly until something that can can seen to the layperson as monumental can be provided. Of course that is FDA approval of HemaXellerate or a source of funding by an entity that offers the "wow" effect so many need.
This does not negate the fact however that they have made their way, quite successfully, over some rather significant hurdles and are still standing with their feet firmly in place.
I truly believe the pps is heavily manipulated. That this stock, as with many before it and many after it I fear, the weaknesses of the less than informed investor coupled with the strong arm of manipulators is causing this pps to pretty much stall as it has.
I firmly believe that this Benitec deal attaches to it a great promise for the company that many were not expecting. The opportunities, by way of affiliation, if nothing else, spells gret promise for the company. Perhaps when they are better able to rub elbows so-to-speak with some of those that they are not indirectly involved with, more attention will paid by those who are in a position to thwart the nefarious actions of a few.
I have seen it many times in this business. There is no reason why Regen should be the exception.
Again, thank you.
News 
Market Data 
Discover 
